Bosentan
（重定向自Tracleer）
![](/Images/godic/202502/17/Bosentan.svg2532.png")
Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer.